4-Piperidinebutanoic acid, 1-(2-cyclobutyl-5,7-dihydro-6,6-dioxidothieno[3,4-d]pyrimidin-4-yl)- manufacturers
- AS1907417
-
- $1520.00
-
2026-05-11
- CAS:885038-66-4
- Purity:
- Supply Ability: 10g
|
| | 4-Piperidinebutanoic acid, 1-(2-cyclobutyl-5,7-dihydro-6,6-dioxidothieno[3,4-d]pyrimidin-4-yl)- Basic information |
| | 4-Piperidinebutanoic acid, 1-(2-cyclobutyl-5,7-dihydro-6,6-dioxidothieno[3,4-d]pyrimidin-4-yl)- Chemical Properties |
| Boiling point | 697.7±55.0 °C(Predicted) | | density | 1.335±0.06 g/cm3(Predicted) | | pka | 4.82±0.10(Predicted) |
| | 4-Piperidinebutanoic acid, 1-(2-cyclobutyl-5,7-dihydro-6,6-dioxidothieno[3,4-d]pyrimidin-4-yl)- Usage And Synthesis |
| Description | AS1907417 is a novel GPR119 agonist. | | Uses | AS1907417 is a novel GPR119 agonist with an oral activity. AS1907417 is a modified form of AS1269574. AS1907417 has antihyperglycemic and can be used in the research of type 2 diabetes[1]. | | References | [1] Shigeru Yoshida, et al. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. Biochem Biophys Res Commun. 2010 Oct 1;400(4):745-51. DOI:10.1016/j.bbrc.2010.08.141 |
| | 4-Piperidinebutanoic acid, 1-(2-cyclobutyl-5,7-dihydro-6,6-dioxidothieno[3,4-d]pyrimidin-4-yl)- Preparation Products And Raw materials |
|